STOCK TITAN

Cardlytics, Inc. (CDLX) executive Cheng files initial insider ownership form

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Cardlytics, Inc. filed an initial insider ownership report for executive Christopher Chi-Kit Cheng, who serves as Chief Legal & Privacy Officer. The report identifies him as an officer of the company and, in this data set, shows no reportable stock transactions or derivative positions.

Positive

  • None.

Negative

  • None.
Buy transactions reported 0 BuyCount in transaction summary for Cheng
Sell transactions reported 0 SellCount in transaction summary for Cheng
Derivative transactions reported 0 derivativeTransactionCount in transaction summary
reporting person regulatory
"Cheng is listed in the reportingPersons section"
Form 3 regulatory
"Form type is indicated as 3 (Form 3)"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Form 3 for Cardlytics (CDLX) disclose about Christopher Chi-Kit Cheng?

The Form 3 identifies Christopher Chi-Kit Cheng as an officer of Cardlytics, serving as Chief Legal & Privacy Officer. It shows no reported stock transactions or derivative positions in this filing data.

Is Christopher Chi-Kit Cheng listed as a 10% owner of Cardlytics (CDLX)?

No. The reporting information marks Cheng’s ten percent owner status as 0, indicating he is not reported as a 10% beneficial owner of Cardlytics in this Form 3 filing.

Does the CDLX Form 3 show any recent stock purchases or sales by Cheng?

No. The transaction summary reports 0 buy transactions and 0 sell transactions for Christopher Chi-Kit Cheng, with no share purchases or sales listed in this Form 3 data.

What executive role does Cheng hold at Cardlytics (CDLX)?

Christopher Chi-Kit Cheng is reported as Chief Legal & Privacy Officer of Cardlytics, Inc. in this Form 3, reflecting his status as an officer and insider of the company.

Are any derivative securities reported for Cheng in the CDLX Form 3?

No. The filing’s derivative summary contains no entries, indicating that no derivative securities positions for Christopher Chi-Kit Cheng are reported in this Form 3 data set.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Cheng Christopher Chi-Kit

(Last)(First)(Middle)
675 PONCE DE LEON AVENUE NE
SUITE 4100

(Street)
ATLANTA GEORGIA 30308

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
08/03/2026
3. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal & Privacy Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
No securities are beneficially owned.
/s/ Chris Cheng08/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)